Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Arango Ossa JE"'
Autor:
Bernard E; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Computational Oncology, UMR 981, Gustave Roussy, Villejuif, France., Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Boston, MA., Greenberg PL; Division of Hematology, Stanford University Cancer Institute, Stanford, CA., Arango Ossa JE; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Creignou M; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Tuechler H; Independent Researcher, Vienna, Austria., Gutierrez-Abril J; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Domenico D; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Medina-Martinez JS; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Levine M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Liosis K; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Farnoud N; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Sirenko M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Jädersten M; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Germing U; Department of Hematology, Oncology, and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany., Sanz G; Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Centro de Investigación Biomédica en Red Cáncer, Instituto de Salud Carlos III, Madrid, Spain., van de Loosdrecht AA; Department of Hematology, Amsterdam University Medical Center, Vrije University Medical Center, Amsterdam, The Netherlands., Nannya Y; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan., Kosmider O; Department of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin and Université de Paris, Université Paris Descartes, Paris, France., Follo MY; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy., Thol F; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Zamora L; Hematology Department, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Barcelona, Spain.; Myelodysplastic Syndromes Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain., Pinheiro RF; Drug Research and Development Center, Federal University of Ceara, Ceara, Brazil., Pellagatti A; Radcliffe Department of Medicine, Nuffield Division of Clinical Laboratory Sciences, University of Oxford, Oxford, United KIngdom., Elias HK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Haase D; Clinics of Hematology and Medical Oncology, University Medical Center, Göttingen, Germany., Ganster C; Clinics of Hematology and Medical Oncology, University Medical Center, Göttingen, Germany., Ades L; Department of Hematology, Hôpital St Louis, and Paris University, Paris, France., Tobiasson M; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Palomo L; Hematology Department, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Barcelona, Spain.; Myelodysplastic Syndromes Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain., Della Porta MG; Department of Biomedical Sciences, Humanitas Clinical and Research Center and Humanitas University, Milan, Italy., Fenaux P; Department of Hematology, Hôpital St Louis, and Paris University, Paris, France., Belickova M; Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Savona MR; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN., Klimek VM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Santos FPS; Oncology-Hematology Center, Hospital Israelita Albert Einstein, São Paulo, Brazil., Boultwood J; Radcliffe Department of Medicine, Nuffield Division of Clinical Laboratory Sciences, University of Oxford, Oxford, United KIngdom., Kotsianidis I; Department of Hematology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece., Santini V; Myelodysplastic Syndromes Unit, Department of Experimental and Clinical Medicine, Hematology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy., Solé F; Myelodysplastic Syndromes Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain., Platzbecker U; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University of Leipzig, Leipzig, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Valent P; Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.; Department of Internal Medicine I, Ludwig Boltzmann Institute for Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Finelli C; Institute of Hematology Seràgnoli, Istituti di Ricovero e Cura a Carattere Scientifico Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Voso MT; Myelodysplastic Syndromes Cooperative Group Gruppo Laziale Mielo-displasie (GROM-L), Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy., Shih LY; Division of Hematology, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan City, Taiwan., Fontenay M; Department of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin and Université de Paris, Université Paris Descartes, Paris, France., Jansen JH; Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands., Cervera J; Department of Hematology and Genetics Unit, University Hospital La Fe, Valencia, Spain., Gattermann N; Department of Hematology, Oncology, and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany., Ebert BL; Department of Medical Oncology and Howard Hughes Medical Institute, Dana-Farber Cancer Center, Boston, MA., Bejar R; University of California San Diego Moores Cancer Center, La Jolla, CA., Malcovati L; Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.; Department of Molecular Medicine, University of Pavia, Pavia, Italy., Ogawa S; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.; Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan., Cazzola M; Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.; Department of Molecular Medicine, University of Pavia, Pavia, Italy., Hellström-Lindberg E; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Papaemmanuil E; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
Publikováno v:
Blood [Blood] 2024 Oct 10; Vol. 144 (15), pp. 1617-1632.
Autor:
Sirenko M; Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY.; Computational Oncology Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Pathology, New York University Grossman School of Medicine, New York, NY., Bernard E; Computational Oncology Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Creignou M; Phase 1 Unit, Center for Clinical Cancer Studies, Karolinska University Hospital, Stockholm, Sweden., Domenico D; Computational Oncology Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Farina A; Integrated Genomics Operation, Memorial Sloan Kettering Cancer Center, New York, NY., Arango Ossa JE; Computational Oncology Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Kosmider O; Institut Cochin, Université de Paris Cité, Paris, France.; Hematology Laboratory, Assistance Publique-Hôpitaux de Paris, Centre-Université de Paris Cité, Cochin Hospital, Paris, France., Hasserjian R; Department of Pathology, Harvard Medical School, Boston, MA., Jädersten M; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska University Hospital, Stockholm, Sweden., Germing U; Department of Hematology, Oncology and Clinical Immunology, Universitatsklinik Dusseldorf, Dusseldorf, Germany., Sanz G; Department of Hematology, Hospital Universitario y Politécnico La Fe, Health Research Institute La Fe, Valencia, Spain., van de Loosdrecht AA; Department of Hematology, Amsterdam University Medical Center, Vrije University Medical Center, Amsterdam, The Netherlands., Gurnari C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Follo MY; Department of Biomedical and Neuromotor Sciences, Cell Signalling Laboratory, University of Bologna, Bologna, Italy., Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Zamora L; Hematology Department, Institut Català d'Oncologia-Hospital Universitari Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain., Pinheiro RF; Department of Clinical Medicine, Federal University of Ceará, Fortaleza, Brazil., Pellagatti A; Radcliffe Department of Medicine, Oxford BRC Haematology Theme, University of Oxford, Oxford, United Kingdom., Elias HK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Haase D; Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Georg-August-University, Göttingen, Germany., Sander B; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden., Orna E; Hematology Department, Institut Català d'Oncologia-Hospital Universitari Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain., Zoldan K; Department of Medicine 1, Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Medical Center Leipzig, Leipzig, Germany., Eder LN; Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Georg-August-University, Göttingen, Germany., Sperr WR; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Thalhammer R; Department of Laboratory Medicine, Medical University of Vienna, Austria., Ganster C; Clinics of Hematology and Medical Oncology, INDIGHO Laboratories, University Medical Center, Göttingen, Germany., Adès L; Department of Hematology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France., Tobiasson M; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden., Palomo L; Experimental Hematology Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Della Porta MG; Cancer Center, Humanitas Research Hospital and Humanitas University, Milan, Italy., Huberman K; Integrated Genomics Operation, Memorial Sloan Kettering Cancer Center, New York, NY., Fenaux P; Department of Hematology, Université de Paris, Saint-Louis Hospital, Paris, France., Belickova M; Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Savona MR; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN., Klimek VM; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Santos FPS; Oncology-Hematology Center, Hospital Israelita Albert Einstein, São Paulo, Brazil., Boultwood J; Nuffield Division of Clinical Laboratory Sciences, Bloodwise Molecular Haematology Unit, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom., Kotsianidis I; Department of Hematology, Democritus Thrace University, School of Medicine, Alexandroupolis, Greece., Santini V; Myelodysplastic Syndromes Unit, Department of Experimental and Clinical Medicine, Hematology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy., Solé F; Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Spain., Platzbecker U; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Leipzig Medical Center, Leipzig, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Finelli C; Institute of Hematology 'Sèragnoli,' IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Voso MT; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Shih LY; Division of Hematology-Oncology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan., Ogawa S; Department of Pathology and Tumor Biology, Kyoto University Graduate School of Medicine, Kyoto, Japan., Fontenay M; Institut Cochin, Université de Paris Cité, Paris, France.; Hematology Laboratory, Assistance Publique-Hôpitaux de Paris, Centre-Université de Paris Cité, Cochin Hospital, Paris, France., Jansen JH; Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Cervera J; Department of Hematology and Genetics Unit, University Hospital La Fe, Valencia, Spain., Ebert BL; Howard Hughes Medical Institute, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Bejar R; Moores Cancer Center at University of California San Diego, La Jolla, CA., Greenberg PL; Hematology Division, Department of Medicine, Stanford Cancer Center, Stanford University, Stanford, CA., Gattermann N; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-Universität, Düsseldorf, Germany., Malcovati L; Department of Molecular Medicine, University of Pavia, Pavia, Italy., Cazzola M; Fondazione Istituto di Ricovero e Cura Carattere Scientifico Policlinico San Matteo, University of Pavia, Pavia, Italy., Beck DB; Division of Rheumatology, Department of Medicine, NYU Grossman School of Medicine, New York, NY., Hellström-Lindberg E; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden., Papaemmanuil E; Computational Oncology Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
Publikováno v:
Blood [Blood] 2024 Sep 12; Vol. 144 (11), pp. 1221-1229.
Autor:
Kinnaman MD; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Zaccaria S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, United Kingdom., Makohon-Moore A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Arnold B; Department of Computer Science, Princeton University, Princeton, New Jersey.; Center for Statistics and Machine Learning, Princeton University, Princeton, New Jersey., Levine MF; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Gundem G; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Arango Ossa JE; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Glodzik D; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Rodríguez-Sánchez MI; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Bouvier N; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Li S; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Stockfisch E; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Dunigan M; Integrated Genomics Operation Core, Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Cobbs C; Integrated Genomics Operation Core, Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Bhanot UK; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Precision Pathology Biobanking Center, Memorial Sloan Kettering Cancer Center, New York, New York., You D; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Mullen K; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Gerstner Sloan Kettering Graduate School of Biomedical Sciences, New York, New York., Melchor JP; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York., Ortiz MV; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., O'Donohue TJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Slotkin EK; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Wexler LH; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Dela Cruz FS; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Hameed MR; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Glade Bender JL; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Tap WD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Meyers PA; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Papaemmanuil E; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Kung AL; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Iacobuzio-Donahue CA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Publikováno v:
Cancer research [Cancer Res] 2023 Nov 15; Vol. 83 (22), pp. 3796-3812.
Autor:
Leongamornlert D; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom., Gutiérrez-Abril J; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Lee S; Department of Haematology, University College London (UCL) Cancer Institute, London, United Kingdom., Barretta E; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Creasey T; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Gundem G; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Levine MF; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Arango-Ossa JE; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Liosis K; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Medina-Martinez JS; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Zuborne Alapi K; Department of Haematology, University College London (UCL) Cancer Institute, London, United Kingdom., Kirkwood AA; Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London, United Kingdom., Clifton-Hadley L; Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London, United Kingdom., Patrick P; Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London, United Kingdom., Jones D; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom., O'Neill L; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom., Butler AP; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom., Harrison CJ; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Campbell P; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom., Patel B; Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University, London, United Kingdom., Moorman AV; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Fielding AK; Department of Haematology, University College London (UCL) Cancer Institute, London, United Kingdom., Papaemmanuil E; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
Publikováno v:
Blood advances [Blood Adv] 2023 Aug 08; Vol. 7 (15), pp. 3862-3873.
Autor:
Gundem G; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. gundemg@mskcc.org.; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. gundemg@mskcc.org., Levine MF; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Roberts SS; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cheung IY; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Medina-Martínez JS; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Feng Y; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Arango-Ossa JE; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chadoutaud L; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rita M; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Asimomitis G; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhou J; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., You D; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bouvier N; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Spitzer B; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Solit DB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, New York, NY, USA., Dela Cruz F; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., LaQuaglia MP; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kushner BH; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Modak S; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shukla N; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Iacobuzio-Donahue CA; The David M. Rubenstein Center for Pancreatic Cancer Research, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kung AL; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cheung NV; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Papaemmanuil E; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. papaemme@mskcc.org.; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. papaemme@mskcc.org.
Publikováno v:
Nature genetics [Nat Genet] 2023 Jun; Vol. 55 (6), pp. 1022-1033. Date of Electronic Publication: 2023 May 11.
Autor:
Tazi Y; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Tri-Institutional Computational Biology and Medicine PhD Program, Weill Cornell Medicine of Cornell University and Rockefeller University, New York, NY, USA.; The Rockefeller University, New York, NY, USA., Arango-Ossa JE; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhou Y; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bernard E; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Thomas I; Centre for Trials Research, School of Medicine, Cardiff University, Cardiff, UK., Gilkes A; Department of Haematology, School of Medicine, Cardiff University, Cardiff, UK., Freeman S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Pradat Y; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Johnson SJ; Centre for Trials Research, School of Medicine, Cardiff University, Cardiff, UK., Hills R; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Dillon R; Department of Medical and Molecular Genetics, King's College, London, UK., Levine MF; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Leongamornlert D; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK., Butler A; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK., Ganser A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Bullinger L; Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Döhner K; Department of Internal Medicine III, Ulm University, Ulm, Germany., Ottmann O; Department of Haematology, School of Medicine, Cardiff University, Cardiff, UK., Adams R; Centre for Trials Research, School of Medicine, Cardiff University, Cardiff, UK., Döhner H; Department of Internal Medicine III, Ulm University, Ulm, Germany., Campbell PJ; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK., Burnett AK; Visiting Professor University of Glasgow, formerly Cardiff University, Cardiff, UK., Dennis M; The Christie NHS Foundation Trust, Manchester, UK., Russell NH; Department of Haematology, Nottingham University Hospital, Nottingham, UK., Devlin SM; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Huntly BJP; Department of Haematology and Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Papaemmanuil E; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. papaemme@mskcc.org.; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA. papaemme@mskcc.org.
Publikováno v:
Nature communications [Nat Commun] 2022 Aug 08; Vol. 13 (1), pp. 4622. Date of Electronic Publication: 2022 Aug 08.
Autor:
Bernard E; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York., Tuechler H, Greenberg PL; Stanford University Cancer Institute, Stanford, CA., Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Boston., Arango Ossa JE; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York., Nannya Y; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.; Division of Hematopoietic Disease Control, Institute of Medical Science, University of Tokyo, Tokyo., Devlin SM; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York., Creignou M; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm., Pinel P; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York., Monnier L; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York., Gundem G; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York., Medina-Martinez JS; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York., Domenico D; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York., Jädersten M; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm., Germing U; Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany., Sanz G; Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid.; Health Research Institute La Fe, Valencia, Spain., van de Loosdrecht AA; Department of Hematology, Amsterdam University Medical Center, Vrije University Medical Center, Amsterdam., Kosmider O; Department of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin and Université de Paris, Université Paris Descartes, Paris., Follo MY; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy., Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Zamora L; Hematology Department, Hospital Germans Trias i Pujol, Institut Català d'Oncologia, Josep Carreras Leukaemia Research Institute, Barcelona., Pinheiro RF; Drug Research and Development Center, Federal University of Ceara, Ceara, Brazil., Pellagatti A; Radcliffe Department of Medicine, Oxford BRC Haematology Theme, University of Oxford, Oxford, United Kingdom., Elias HK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York., Haase D; Clinics of Hematology and Medical Oncology, University Medical Center, Göttingen, Germany., Ganster C; Clinics of Hematology and Medical Oncology, University Medical Center, Göttingen, Germany., Ades L; Department of Hematology, Hôpital St Louis, and Paris University, Paris., Tobiasson M; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm., Palomo L; Myelodysplastic Syndromes Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Barcelona., Della Porta MG; Cancer Center, Humanitas Research Hospital & Humanitas University, Milan., Takaori-Kondo A; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Ishikawa T; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan., Chiba S; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan., Kasahara S; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Miyazaki Y; Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan., Viale A; Integrated Genomics Operation, Memorial Sloan Kettering Cancer Center, New York., Huberman K; Integrated Genomics Operation, Memorial Sloan Kettering Cancer Center, New York., Fenaux P; Department of Hematology, Hôpital St Louis, and Paris University, Paris., Belickova M; Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Savona MR; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville., Klimek VM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York., Santos FPS; Oncology-Hematology Center, Hospital Israelita Albert Einstein, São Paulo., Boultwood J; Radcliffe Department of Medicine, Oxford BRC Haematology Theme, University of Oxford, Oxford, United Kingdom., Kotsianidis I; Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece., Santini V; Myelodysplastic syndromes Unit, Department of Experimental and Clinical Medicine, Hematology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy., Solé F; Myelodysplastic Syndromes Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Barcelona., Platzbecker U; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University of Leipzig, Leipzig, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Valent P; Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna., Ohyashiki K; Tokyo Medical University, Tokyo., Finelli C; Institute of Hematology 'Seràgnoli,' Istituti di Ricovero e Cura a Carattere Scientifico Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Voso MT; Myelodysplastic syndromes Cooperative Group Gruppo Laziale Mielodisplasie (GROM-L), Department of Biomedicine and Prevention, Tor Vergata University, Rome., Shih LY; Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taiwan., Fontenay M; Department of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin and Université de Paris, Université Paris Descartes, Paris., Jansen JH; Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands., Cervera J; Department of Hematology and Genetics Unit, University Hospital La Fe, Valencia, Spain., Gattermann N; Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany., Ebert BL; Department of Medical Oncology, Howard Hughes Medical Institute, Dana-Farber Cancer Center, Boston., Bejar R; University of California San Diego Moores Cancer Center, La Jolla, CA., Malcovati L; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo and University of Pavia, Pavia, Italy., Cazzola M; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo and University of Pavia, Pavia, Italy., Ogawa S; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.; Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan.; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm., Hellström-Lindberg E; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm., Papaemmanuil E; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York.
Publikováno v:
NEJM evidence [NEJM Evid] 2022 Jul; Vol. 1 (7), pp. EVIDoa2200008. Date of Electronic Publication: 2022 Jun 12.
Autor:
Shukla N; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Levine MF; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gundem G; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Domenico D; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Spitzer B; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bouvier N; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Arango-Ossa JE; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Glodzik D; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Medina-Martínez JS; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bhanot U; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Precision Pathology Biobanking Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gutiérrez-Abril J; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhou Y; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Fiala E; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Stockfisch E; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Li S; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rodriguez-Sanchez MI; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., O'Donohue T; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cobbs C; Integrated Genomics Operation Core, Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Roehrl MHA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Precision Pathology Biobanking Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Benhamida J; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Iglesias Cardenas F; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ortiz M; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kinnaman M; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Roberts S; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ladanyi M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Modak S; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Farouk-Sait S; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Slotkin E; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Karajannis MA; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Dela Cruz F; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Glade Bender J; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zehir A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Viale A; Integrated Genomics Operation Core, Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Walsh MF; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kung AL; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. kunga@mskcc.org., Papaemmanuil E; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. papaemme@mskcc.org.; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. papaemme@mskcc.org.
Publikováno v:
Nature communications [Nat Commun] 2022 May 18; Vol. 13 (1), pp. 2485. Date of Electronic Publication: 2022 May 18.
Autor:
Mascarenhas J; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Kosiorek HE; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ., Prchal JT; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Rambaldi A; Hematology and Bone Marrow Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Berenzon D; Comprehensive Cancer Center, Wake Forest Baptist Health, Comprehensive Cancer Center, Winston-Salem, NC., Yacoub A; Kansas University Cancer Center, Leawood, KS., Harrison CN; Department of Haematology, Guy's Hospital, London, United Kingdom., McMullin MF; Queen's University Belfast, Belfast, United Kingdom., Vannucchi AM; University of Florence, Azienda Ospedaliero Universitaria Careggi, Florence, Italy., Ewing J; Heart of England NHS Foundation Trust, UHB, Birmingham, United Kingdom., O'Connell CL; Keck School of Medicine, University of Southern California, Los Angeles, CA., Kiladjian JJ; Université de Paris, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM, Paris, France., Mead AJ; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Winton EF; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Leibowitz DS; Oncology Department, Palo Alto Medical Foundation Sutter Health, Cupertino, CA., De Stefano V; Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico Universitario A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Arcasoy MO; Duke University School of Medicine, Durham, NC., Kessler CM; Georgetown University Medical Center, Washington, DC., Catchatourian R; Oncology Department, John H. Stroger Jr Hospital of Cook County, Chicago, IL., Rondelli D; Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL., Silver RT; Richard T. Silver Myeloproliferative Neoplasms Center, New York Presbyterian Weill Cornell Medical Center, New York, NY., Bacigalupo A; Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico Universitario A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Nagler A; Hematology Department, Chaim Sheba Medical Center, Tel Hashomer, Israel., Kremyanskaya M; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Levine MF; Center for Hematologic Malignancies, Memorial Sloan-Kettering Cancer Center, New York, NY., Arango Ossa JE; Center for Hematologic Malignancies, Memorial Sloan-Kettering Cancer Center, New York, NY., McGovern E; Center for Hematologic Malignancies, Memorial Sloan-Kettering Cancer Center, New York, NY., Sandy L; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Salama ME; Mayo Clinic, Rochester, MN., Najfeld V; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Tripodi J; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Farnoud N; Center for Hematologic Malignancies, Memorial Sloan-Kettering Cancer Center, New York, NY., Penson AV; Center for Hematologic Malignancies, Memorial Sloan-Kettering Cancer Center, New York, NY., Weinberg RS; New York Blood Center, New York, NY., Price L; Department of Population Health and., Goldberg JD; Department of Population Health and.; Department of Environmental Medicine, New York University School of Medicine, New York, NY., Barbui T; Papa Giovanni XXIII Hospital, Foundation for Clinical Research (FROM), Bergamo, Italy., Marchioli R; Cardiovascular, Renal and Metabolic Medical and Scientific Services, IQVIA, Milan, Italy., Tognoni G; Department of Anaesthesia and Emergency Urgency, IRCCS, Ospedale Maggiore Policlinico, Milan, Italy., Rampal RK; Leukemia Service, Department of Medicine, Center for Hematologic Malignancies, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, Myeloproliferative Neoplasm Research Consortium (MPN-RC), New York, NY; and., Mesa RA; UT Health San Antonio Cancer Center, San Antonio, TX., Dueck AC; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ., Hoffman R; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Publikováno v:
Blood [Blood] 2022 May 12; Vol. 139 (19), pp. 2931-2941.
Autor:
Spitzer B; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pediatrics, Weill Cornell Medical College, New York, New York., Rutherford KD; Center for Computational Oncology, Department of Epidemiology and Statistics, Memorial Sloan Kettering Cancer Center, New York, New York., Gundem G; Center for Computational Oncology, Department of Epidemiology and Statistics, Memorial Sloan Kettering Cancer Center, New York, New York., McGovern EM; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Millard NE; Division of Hematology/Oncology, Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington., Arango Ossa JE; Center for Computational Oncology, Department of Epidemiology and Statistics, Memorial Sloan Kettering Cancer Center, New York, New York., Cheung IY; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Gao T; Bioinformatics and Integrative Genomics, Harvard Medical School, Boston, Massachusetts., Levine MF; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Computational Oncology, Department of Epidemiology and Statistics, Memorial Sloan Kettering Cancer Center, New York, New York., Zhang Y; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Medina-Martínez JS; Center for Computational Oncology, Department of Epidemiology and Statistics, Memorial Sloan Kettering Cancer Center, New York, New York., Feng Y; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Ptashkin RN; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Bolton KL; Division of Oncology, Department of Medicine, Washington University, St. Louis, Missouri., Farnoud N; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Zhou Y; Center for Computational Oncology, Department of Epidemiology and Statistics, Memorial Sloan Kettering Cancer Center, New York, New York., Patel MA; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Asimomitis G; Center for Computational Oncology, Department of Epidemiology and Statistics, Memorial Sloan Kettering Cancer Center, New York, New York., Cobbs CC; Integrated Genomics Core, Memorial Sloan Kettering Cancer Center, New York, New York., Mohibullah N; Integrated Genomics Core, Memorial Sloan Kettering Cancer Center, New York, New York., Huberman KH; Integrated Genomics Core, Memorial Sloan Kettering Cancer Center, New York, New York., Arcilla ME; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Kushner BH; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Modak S; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Kung AL; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Zehir A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Levine RL; Human Oncology and Oncogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Armstrong SA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Cheung NKV; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Papaemmanuil E; Center for Computational Oncology, Department of Epidemiology and Statistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Apr 14; Vol. 28 (8), pp. 1614-1627.